What this consultation may focus on.
Reviewing biopsy and blood-test findings
Staging and risk assessment
Chemotherapy, immunotherapy and antibody-treatment planning where appropriate
Treatment-response assessment
Long-term monitoring and supportive care
Decisions made from the whole clinical picture.
Lymphoma and other blood cancers are biologically diverse. Accurate diagnosis often depends on pathology, immunophenotyping, blood tests, imaging and sometimes additional specialised tests. Treatment is selected according to the exact diagnosis, stage, risk features and patient factors.
Common reasons patients seek an oncology review.
- A lymph-node biopsy suggests lymphoma
- Persistent abnormal blood findings need oncology review
- Systemic treatment has been recommended for lymphoma
- You need treatment monitoring or follow-up after therapy
Questions patients often ask.
Are all lymphomas treated the same way?
No. Hodgkin lymphoma and the many types of non-Hodgkin lymphoma can require different treatment approaches. Precise pathology is important before planning therapy.
Can immunotherapy be used for lymphoma?
Some lymphomas can be treated with immune-based or antibody treatments, often in combination with other medicines. Suitability depends on the lymphoma subtype and treatment setting.
Why can additional tests be needed after a biopsy?
Lymphoma classification can require specialised testing to define the exact subtype. This information can directly influence the treatment plan.